J&J acquires interest in J&J-Merck JV
The affiliates of J&J include McNEIL-PPC, McNEIL MMP, LLC, and Johnson & Johnson. Following the agreement, J&J will own the venture’s assets which comprise exclusive rights to market
HAYA Therapeutics has secured fast track designation from the US Food and Drug Administration (FDA) for its investigational therapy, HTX-001, to treat symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM).